Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trial.

ABSTRACT:

SUBMITTER: Groeneweg S 

PROVIDER: S-EPMC7611958 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature